Peptide Nasal Sprays For Research

5-Amino-1MQ Spray (5-Amino-1-methylquinolinium) is a research-grade small molecule selective inhibitor of the enzyme nicotinamide N-methyltransferase (NNMT), formulated in a pre-metered liquid vehicle for non-invasive laboratory research. By preventing the methylation of nicotinamide, 5-Amino-1MQ increases intracellular S-adenosylmethionine (SAM) and NAD+ levels, activating SIRT1, AMPK, and downstream mitochondrial biogenesis. Formulated as a stabilized solution, each bottle contains total active compound, analytically verified by HPLC to support reproducible scientific investigations.

AHK-Cu Spray (Copper Tripeptide-3) is a research-grade synthetic copper-complexed tripeptide formulated in a pre-metered liquid vehicle for non-invasive laboratory research. Consisting of a stabilized aqueous solution with total active peptide, AHK-Cu (sequence: Ala-His-Lys-Cu) selectively complexes with divalent copper (Cu2+). Formulated to study follicular and dermal cellular dynamics, each bottle supports reproducible investigations in extracellular matrix synthesis and localized angiogenesis.

AOD9604 Spray (Advanced Obesity Drug 9604) is a research-grade synthetic cyclic peptide analog derived from the C-terminus of human Growth Hormone (hGH), formulated in a pre-metered liquid vehicle for non-invasive laboratory research. Representing hGH residues 177-191 with a C-terminal cyclizing tyrosine residue, AOD9604 (sequence: Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe, disulfide bridged) selectively stimulates lipolysis. Formulated as a stabilized solution at a strength of, each bottle supports reproducible lipolytic and fat metabolism investigations.

ARA-290 Spray (Cibinetide) is a research-grade synthetic 11-amino-acid peptide derived from erythropoietin (EPO), formulated in a pre-metered liquid vehicle for non-invasive laboratory research. Functioning as a highly selective agonist of the Innate Repair Receptor (IRR), ARA-290 (sequence: pyroGlu-Glu-Gln-Leu-Glu-Arg-Ala-Leu-Asn-Ser-Ser-OH) is studied for its potent anti-inflammatory, cytoprotective, and neuro-regenerative effects. Formulated as a stabilized solution, each bottle contains total active peptide, analytically verified by HPLC to support reproducible scientific investigations.

BPC/TB-500 5/5mg Spray is a combined research formulation containing 5mg of BPC-157 and 5mg of TB-500. The two peptides have been investigated separately in preclinical research related to tissue repair, angiogenesis, cellular responses, and inflammation. Direct evidence for the specific combination and spray formulation is much more limited, so the product should be studied as a combined experimental system rather than assuming that findings from either peptide alone establish an effect for the combination.

BPC-157 Spray is a research-grade peptide nasal spray available in 5mg and 10mg strengths, studied for peptide signaling, cellular communication, and tissue biology research.

Cagrilintide Spray is a research-grade synthetic acylated amylin analog formulated in a pre-metered liquid vehicle for non-invasive laboratory research. As a long-acting co-agonist targeting both amylin receptors (AMY1, AMY2, AMY3) and calcitonin receptors (CTR), Cagrilintide is investigated for its capacity to stimulate hindbrain satiety pathways, delay gastric emptying, and modulate glucagon secretion. Formulated as a stabilized solution, each bottle contains total active peptide, analytically verified by HPLC to support reproducible scientific investigations in metabolic regulation and mucosal delivery kinetics.

CJC/Ipamorelin 5/5mg Spray is a research-grade synergistic peptide blend formulated in a pre-metered liquid vehicle for non-invasive laboratory research. Combining CJC-1295 No DAC (Modified GRF 1-29, GHRH agonist) and Ipamorelin (selective GHSR agonist), this dual-action solution stimulates pulsatile growth hormone secretion via complementary cellular pathways. Formulated as a stabilized solution, each bottle contains 5mg of CJC-1295 No DAC and 5mg of Ipamorelin, analytically verified by HPLC to support reproducible scientific investigations in endocrinology and mucosal transport kinetics.

CJC-1295 No DAC spray (also known as Modified GRF 1-29 or Mod GRF 1-29) is a research-grade synthetic GHRH analog formulated in a pre-metered liquid vehicle for non-invasive laboratory research. As a tetrasubstituted 29-amino-acid peptide, it targets GHRH receptors on pituitary somatotrophs to stimulate pulsatile growth hormone secretion. Formulated as a stabilized solution without Drug Affinity Complex (DAC), each bottle contains total active peptide, analytically verified by HPLC to support reproducible scientific investigations in endocrinology and mucosal transport kinetics.

CJC-1295 W/DAC spray is a research-grade synthetic GHRH analog conjugated to a Drug Affinity Complex (DAC), formulated in a pre-metered liquid vehicle for non-invasive laboratory research. Consisting of a modified GHRH(1-29) peptide linked to a maleimidopropionic acid group, it covalently binds to endogenous albumin to evaluate extended, non-pulsatile somatotroph stimulation. Formulated as a stabilized solution, each bottle contains total active peptide, analytically verified by HPLC to support reproducible scientific investigations in endocrinology and mucosal transport kinetics.

DSIP Spray 10mg is a research-grade intranasal peptide formulation developed for laboratory investigations involving Delta Sleep-Inducing Peptide (DSIP), neuropeptide signaling, circadian biology, and molecular pharmacology. The standardized spray formulation supports investigations into peptide stability, formulation science, receptor biology, and intranasal delivery systems while maintaining rigorous analytical quality standards for Research Use Only applications.

Epitalon Spray is a research-grade peptide nasal spray studied in laboratory environments for peptide signaling, telomere biology, and cellular communication research.

GHK-Cu Spray is a research-grade copper peptide nasal spray available in 50mg and 100mg strengths, studied for copper peptide signaling, extracellular matrix biology, and cellular communication research.

GHRP-2 Spray (Pralmorelin) is a research-grade synthetic growth hormone secretagogue receptor (GHSR) agonist hexapeptide formulated in a pre-metered liquid vehicle for non-invasive laboratory research. Targeting somatotropic pathways, GHRP-2 (sequence: D-Ala-D-2-Nal-Ala-Trp-D-Phe-Lys-NH2) is studied for its capacity to stimulate pulsatile endogenous growth hormone secretion, modulate hypothalamic appetite signaling, and interact with the HPA axis. Formulated as a stabilized solution at a high-strength concentration, each bottle contains analytically verified peptide by HPLC to support reproducible scientific investigations.

GHRP-6 Spray is a research-grade synthetic growth hormone secretagogue receptor (GHSR) agonist hexapeptide formulated in a pre-metered liquid vehicle for non-invasive laboratory research. Targeting endocrine pathways, GHRP-6 (sequence: His-D-Trp-Ala-Trp-D-Phe-Lys-NH2) is studied for its capacity to stimulate pulsatile endogenous growth hormone secretion, modulate hypothalamic appetite signaling, and exert tissue-protective anti-inflammatory activity. Formulated as a stabilized solution, each bottle contains total active peptide, analytically verified by HPLC to support reproducible scientific investigations.

Glow Spray is a research-grade tri-peptide blend combining three well-characterized investigational compounds — GHK-Cu (glycyl-L-histidyl-L-lysine copper, 50mg), BPC-157 (Body Protective Compound-157, 10mg), and TB-500 (Thymosin Beta-4 synthetic fragment, 10mg) — into a single research spray formulation. Each component contributes a distinct and scientifically documented signaling profile: GHK-Cu for extracellular matrix regulation and antioxidant gene expression, BPC-157 for nitric oxide and growth factor receptor signaling, and TB-500 for actin cytoskeleton dynamics and cell migration research. Each batch is analytically verified and manufactured exclusively for laboratory research applications.

Glp-1TRZ Spray is a research-grade synthetic dual GIP and GLP-1 receptor agonist peptide formulated in a pre-metered liquid vehicle for non-invasive laboratory research. As a lipidated 39-amino-acid peptide (C20 fatty diacid attached via a hydrophilic linker at Lys20), Glp-1TRZ (sequence: GIP-derived base) is highly resistant to enzymatic degradation. Formulated as a stabilized solution at a strength of, each bottle contains analytically verified peptide by HPLC to support reproducible metabolic and glucose regulation investigations.

H Frag Spray (hGH Fragment 176-191) is a research-grade synthetic C-terminal fragment of human growth hormone formulated in a pre-metered liquid vehicle for non-invasive laboratory research. Designed to isolate the lipid-mobilizing domain of growth hormone, H Frag (sequence: Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe) is widely studied for its ability to stimulate lipolysis and inhibit lipogenesis without affecting blood glucose levels or elevating IGF-1. Formulated as a stabilized solution, each bottle contains total active peptide, analytically verified by HPLC to support reproducible scientific investigations.

HCG Spray (Human Chorionic Gonadotropin) is a research-grade heterodimeric glycoprotein hormone formulated in a pre-metered liquid vehicle for non-invasive laboratory research. Acting as a potent agonist of the luteinizing hormone/choriogonadotropin receptor (LHCGR), HCG is widely studied for its capacity to stimulate gonadal steroidogenesis, evaluate pituitary-gonadal feedback loops, and investigate macromolecular macromolecular transport kinetics. Formulated as a stabilized solution, each bottle contains total biological activity, analytically verified to support reproducible scientific investigations.

IGF-LR3 Spray (Long Arg3 Insulin-like Growth Factor-1) is a research-grade synthetic polypeptide formulated in a pre-metered liquid vehicle for non-invasive laboratory research. Designed as a long-acting IGF-1 analog, IGF-LR3 (an 83-amino-acid peptide with N-terminal extension and Glu3Arg mutation) is widely studied for its ability to activate the IGF-1 receptor (IGF-1R) while evading inhibitory IGF-binding proteins (IGFBPs). Formulated as a stabilized solution, each bottle contains total active peptide, analytically verified by HPLC to support reproducible scientific investigations in cell survival and mucosal transport kinetics.

Ipamorelin Spray is a research-grade synthetic selective growth hormone secretagogue receptor (GHSR) agonist pentapeptide formulated in a pre-metered liquid vehicle for non-invasive laboratory research. Characterized by its exceptional receptor selectivity, Ipamorelin (sequence: Aib-His-D-2-Nal-D-Phe-Lys-NH2) is widely studied for its capacity to stimulate pulsatile endogenous growth hormone secretion without elevating ACTH, cortisol, or prolactin levels. Formulated as a stabilized solution, each bottle contains total active peptide, analytically verified by HPLC to support reproducible scientific investigations.

Kisspeptin Spray (Kisspeptin-10 / KP-10) is a research-grade synthetic decapeptide G-protein coupled receptor 54 (GPR54 / KISS1R) agonist formulated in a pre-metered liquid vehicle for non-invasive laboratory research. Functioning as the primary upstream regulator of the Hypothalamic-Pituitary-Gonadal (HPG) axis, Kisspeptin (sequence: Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Phe-NH2) is studied for its ability to trigger hypothalamic GnRH release, stimulate LH/FSH secretion, and modulate metastasis pathways. Formulated as a stabilized solution, each bottle contains total active peptide, analytically verified by HPLC to support reproducible scientific investigations.

KLOW Spray is a research-grade multi-peptide blend formulated in a pre-metered liquid vehicle for non-invasive laboratory research. Consisting of a synergistic four-peptide combination, each bottle delivers total active peptides: GHK-Cu (50mg), BPC-157 (10mg), TB-500 (10mg), and KPV (10mg). Designed to investigate cellular regeneration and inflammatory pathway regulation, this stabilized solution enables researchers to study extracellular matrix remodeling, accelerated wound healing, and MC1-receptor mediated cytoprotection in mucosal transport models.

KPV Spray 5mg is a research-grade intranasal peptide formulation developed for laboratory investigations involving KPV (Lys-Pro-Val), melanocortin biology, peptide signaling, and molecular pharmacology. The standardized spray formulation supports investigations into peptide stability, formulation science, receptor biology, and intranasal delivery systems while maintaining rigorous analytical quality standards for Research Use Only applications.